Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-01

FDA Approved: DROXIDOPA — Original Application (Slate Run Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved the original application for droxidopa from Slate Run Pharmaceuticals, LLC, enabling its market authorization for treating neurogenic orthostat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Droxidopa (Droxidopa)

Snippet

ORIG AP for DROXIDOPA (DROXIDOPA)